XCUR - Exicure stock sinks postmarket on weak results going concern risk

Exicure (NASDAQ:XCUR) stock sinks 21% postmarket after the firm posted weak 2021 results and raised concern over its ability to continue as a going concern in the next 1 year. Revenue was -$0.5M in 2021, down $17.1M from 2020, due to a decrease in non-cash revenue of $19.3M associated with XCUR's collaboration with AbbVie. XCUR reported 2021 net loss of $64.1M vs. net loss of $24.7M in 2020. The wider loss was driven by lower non-cash revenue largely hit by the reversal of non-cash revenue in 2021 associated with the AbbVie collaboration as well as higher R&D and G&A costs. XCUR's expectation to continue to generate operating losses and negative operating cash flows, and the need for additional funding raise substantial doubt over its ability to continue as a going concern within 1 year after filing its 2021 results. XCUR will require additional financing to address its working capital and other

For further details see:

Exicure stock sinks postmarket on weak results, going concern risk